Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance
Status:
Completed
Trial end date:
1997-06-01
Target enrollment:
Participant gender:
Summary
Oral enzyme therapy in patients with acute superficial vein inflammation (thrombophlebitis)
can serve as an additional treatment option besides standard therapy with compression
stockings, common pain medication and physical treatments. This randomized, double-blinded
trial compares efficacy and safety with placebo.